The conclusions of a new survey regarding quality of life for Ulcerative Colitis patients were recently released online and through social media channels as a means of improving care and treatment of the disease. The survey, which was commissioned and funded by MSD, the UK subsidiary of Merck & Co., Inc., together with Crohn’s and Colitis UK (CCUK), studied 684 people with Ulcerative Colitis (UC) who answered questions regarding the level of disease control, the impact on quality of life, treatment satisfaction, and satisfaction after having a colectomy, a surgical procedure where the colon is removed, partially or completely. The majority of the surveyed patients were women (74%), and the ages varied between less than 24 years old (18%), 25–39 (46%) and 40–54 years of age (29%). Between the participants, nearly 1 in 10 had undergone a colectomy. These patients reported frequent fatigue (74%), abdominal pain (54%) and diarrhea (33%). While fatigue was reported as the worst symptom to cope with, the most common post-operative complications were related to infections (43%), followed by pouch leakage (31%) and pouchitis (23%), a condition characterized by inflammation of the ileal pouch (an artificial rectum surgically created out of ileal gut tissue in patients who have had a colectomy).